Search results
PANDA II: In-hospital Influenza Vaccination Reduces Mortality and Readmission in Acute Heart Failure
Added:
9 months ago
Source:
Radcliffe Cardiology
News
Author(s):
Ross Campbell
Added:
1 month ago
HFA Congress 2026 — SUBCUT-HF II: subcutaneous furosemide for early supported discharge in worsening heart failure. Dr Ross Campbell (University of Glasgow, UK) shares results from SUBCUT-HF II, a multicentre, phase 2, randomised controlled trial evaluating subcutaneous furosemide in patients hospitalised with worsening heart failure.A total of 172 patients across 22 UK centres were randomised to…
View more
Effects of GLP-1 Receptor Agonists in Heart Failure Patients
Author(s):
Anastasia Shchendrygina
,
Amina Rakisheva
,
Ilya Giverts
,
et al
Added:
1 year ago
Review Article
Author(s):
Kevin Damman
Added:
1 month ago
HFA Congress 2026 - Dr Kevin Damman (University Medical Centre Groningen, Groningen, NL) joins us to discuss findings from a study-level meta-analysis combining data from the DECISION, DIGIT-HF and DIG trials to evaluate the role of digitalis glycosides (digoxin and digitoxin) in heart failure with reduced and mildly reduced ejection fraction.This analysis brings together evidence from three…
View more
Device Therapies in Heart Failure
Author(s):
Yoel Benarroch
,
Natalie Tapaskar
,
Amin Yehya
Added:
9 months ago
Review Article
Hypertrophic Cardiomyopathy: a Review
Author(s):
Sukriti Banthiya
,
Larissa Check
,
Jessica Atkins
Added:
1 year ago
Review Article
Author(s):
Diana Hui Ping Foo
Added:
1 year ago
ESC HF 25 - Findings from Heart2Miss suggest a hub-and-spoke model for early heart failure detection can detect patients with pre-HF and HF who were previously undiagnosed, can reduce tertiary center overload and improve novice performance.Dr Diana Foo (Sarawak General Hospital, Kuching, MY) discusses the findings from the Heart2Miss study, investigating a decentralised, community-based, rapid,…
View more
Author(s):
Ankeet Bhatt
Added:
1 year ago
ESC HF 25 - Secondary analysis of the FINEARTS-HF study shows finerenone treatment favourably influenced the risk of early heart failure readmission.Dr Ankeet Bhatt (Kaiser Permanante San Francisco Medical Center, San Francisco, US) discusses findings from the prespecified secondary analysis of the FINEARTS-HF trial (NCT04435626; Bayer). The placebo-controlled primary analysis investigated the…
View more
Author(s):
Stefan Stork
Added:
1 year ago
ESC HF 25 - A secondary analysis of TIM-HF2 showed that patients residing farther from their cardiologist benefited further from remote patient management (RPM).Prof Stefan Störk (University Hospital Wuerzburg, DE) discusses the findings from a pre-specified, secondary analysis of TIM-HF2, investigating the impact of rurality and travel distance on the effectiveness of RPM in patients…
View more
Author(s):
Nicolas Girerd
Added:
1 year ago
ESC HF 25 - Real-world findings suggest kidney function decline could precede heart failure events by up to a year.Prof Nicolas Girerd (University Hospital of Nancy, Nancy, FR) discusses real-world findings from pooled trials EPHESUS, EMPHASIS-HF and BARCELONA. The study investigated if longitudinal changes in kidney function could help identify patients with HFrEF at a higher risk of…
View more